Jidong Shan

611 total citations
18 papers, 357 citations indexed

About

Jidong Shan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jidong Shan has authored 18 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jidong Shan's work include Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (3 papers) and Acute Myeloid Leukemia Research (2 papers). Jidong Shan is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (3 papers) and Acute Myeloid Leukemia Research (2 papers). Jidong Shan collaborates with scholars based in United States, China and Switzerland. Jidong Shan's co-authors include Haopeng Xu, Daniel R. Budman, Vincent Vinciguerra, Vladimir Jurukovski, Michele Barcia, James Mason, David Gal, John L. Lovecchio, John D. Broome and Jianhua Li and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Jidong Shan

18 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jidong Shan United States 11 248 75 70 55 31 18 357
Ting‐Yu Lin Taiwan 10 178 0.7× 69 0.9× 55 0.8× 53 1.0× 19 0.6× 17 317
Xiaobin Yu China 12 164 0.7× 87 1.2× 60 0.9× 65 1.2× 27 0.9× 19 327
Emilie Evanno France 6 208 0.8× 62 0.8× 52 0.7× 72 1.3× 12 0.4× 7 334
Michiko Murohashi Japan 8 251 1.0× 63 0.8× 27 0.4× 43 0.8× 27 0.9× 8 338
Michiya Noguchi Japan 7 199 0.8× 45 0.6× 88 1.3× 48 0.9× 19 0.6× 22 494
Weiwei Yi China 9 180 0.7× 53 0.7× 68 1.0× 42 0.8× 17 0.5× 13 325
Yuki Yoshino Japan 10 228 0.9× 91 1.2× 75 1.1× 54 1.0× 13 0.4× 24 372
Suzanne B.R. Jacobs United States 9 312 1.3× 60 0.8× 66 0.9× 69 1.3× 59 1.9× 11 476
Yayun Zheng China 8 371 1.5× 30 0.4× 82 1.2× 58 1.1× 20 0.6× 13 486

Countries citing papers authored by Jidong Shan

Since Specialization
Citations

This map shows the geographic impact of Jidong Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jidong Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jidong Shan more than expected).

Fields of papers citing papers by Jidong Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jidong Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jidong Shan. The network helps show where Jidong Shan may publish in the future.

Co-authorship network of co-authors of Jidong Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Jidong Shan. A scholar is included among the top collaborators of Jidong Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jidong Shan. Jidong Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Skvir, Nicholas, Brian W. Gould, Jidong Shan, et al.. (2024). A longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring. Aging Cell. 24(1). e14351–e14351. 3 indexed citations
2.
Slevin, Michael K., et al.. (2024). Neotelomeres and telomere-spanning chromosomal arm fusions in cancer genomes revealed by long-read sequencing. Cell Genomics. 4(7). 100588–100588. 6 indexed citations
3.
Chen, Jie, Runxiang Yang, Hao Wu, et al.. (2024). 1278P Update of the INSPIRE study: Iruplinalkib versus crizotinib in ALK TKI-naïve locally advanced or metastatic ALK+ non-small cell lung cancer (NSCLC). Annals of Oncology. 35. S815–S815. 1 indexed citations
4.
Ames, Kristina, Yang Shi, Meng Tong, et al.. (2023). PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells. Science Advances. 9(8). eade8222–eade8222. 9 indexed citations
5.
Shuter, Jonathan, H. Dean Hosgood, Ryung S. Kim, et al.. (2021). Behavioral and Genetic Factors Associated with Successful Long-Term Cessation in Persons with HIV Who Smoke Cigarettes. The Journal of Smoking Cessation. 2021. 1894160–1894160. 1 indexed citations
6.
Ames, Kristina, Yang Shi, Robert Dubin, et al.. (2021). PI3-Kinase Deletion Dysregulates Autophagy in HSCs and Promotes Myelodysplasia. Blood. 138(Supplement 1). 323–323. 1 indexed citations
7.
Cleven, Krystal L., Kenny Ye, Rachel Zeig‐Owens, et al.. (2019). Genetic Variants Associated with FDNY WTC-Related Sarcoidosis. International Journal of Environmental Research and Public Health. 16(10). 1830–1830. 22 indexed citations
8.
Ruf-Zamojski, Frederique, Yongchao Ge, Hanna Pinças, et al.. (2019). Cytogenetic, Genomic, and Functional Characterization of Pituitary Gonadotrope Cell Lines. Journal of the Endocrine Society. 3(5). 902–920. 12 indexed citations
9.
Ma, Weijie, Jidong Shan, Wenwu Xiao, et al.. (2018). Safety and Efficacy of Osimertinib in the Treatment of a Patient With Metastatic Lung Cancer and Concurrent Somatic EGFR L858R and Germline EGFR T790M Mutations. JCO Precision Oncology. 2(2). 1–7. 3 indexed citations
10.
Shan, Jidong, Raquel Castellanos, Melanie Babcock, et al.. (2010). GJB2 mutation spectrum in 209 hearing impaired individuals of predominantly Caribbean Hispanic and African descent. International Journal of Pediatric Otorhinolaryngology. 74(6). 611–618. 19 indexed citations
11.
Xu, Haopeng, et al.. (2007). TSP50 Encodes a Testis-Specific Protease and Is Negatively Regulated by p53. Cancer Research. 67(3). 1239–1245. 40 indexed citations
12.
Jurukovski, Vladimir, et al.. (2005). WTH3, which Encodes a Small G Protein, Is Differentially Regulated in Multidrug-Resistant and Sensitive MCF7 Cells. Cancer Research. 65(16). 7421–7428. 11 indexed citations
13.
Shan, Jidong, et al.. (2004). Localization and expression of TSP50 protein in human and rodent testes. Urology. 64(4). 826–832. 33 indexed citations
14.
Shan, Jidong, et al.. (2002). WTH3, a new member of the Rab6 gene family, and multidrug resistance. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1589(2). 112–123. 19 indexed citations
15.
Mason, James, Andrew Leask, Michele Barcia, et al.. (2002). Lefty Contributes to the Remodeling of Extracellular Matrix by Inhibition of Connective Tissue Growth Factor and Collagen mRNA Expression and Increased Proteolytic Activity in a Fibrosarcoma Model. Journal of Biological Chemistry. 277(1). 407–415. 34 indexed citations
16.
Shan, Jidong, et al.. (2002). TSP50, a possible protease in human testes, is activated in breast cancer epithelial cells.. PubMed. 62(1). 290–4. 52 indexed citations
17.
Shan, Jidong, James Mason, Michele Barcia, et al.. (2000). Rab6c, a new member of the Rab gene family, is involved in drug resistance in MCF7/AdrR cells. Gene. 257(1). 67–75. 33 indexed citations
18.
Shan, Jidong, John D. Broome, John L. Lovecchio, et al.. (1999). Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer.. PubMed. 59(13). 3215–21. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026